摘要
目的 :探讨川芎嗪对糖尿病性视网膜病防治作用的机理。方法 :用链脲佐菌素 (STZ)制作糖尿病大鼠动物模型 ,分为正常对照组、糖尿病对照组、糖尿病川芎嗪治疗组 ,于第 12周测定各组大鼠视网膜组织NOS和AR活性 ,用免疫组化方法观察其VEGF表达的变化。结果 :川芎嗪治疗组大鼠视网膜组织NOS和AR活性、VEGF的表达显著低于糖尿病对照组。结论 :川芎嗪能够抑制糖尿病大鼠视网膜组织NOS和AR活性 ,减少VEGF的表达 ,从而对糖尿病性视网膜病起防治作用。
Object: To investigate the protective effect of Tetramethylprazine (TMP) on diabetic retinopathy and explore its possible mechanism. Method: After 12 weeks the activities of retinal tissue nitric oxide syntheses (NOS) and aldose reductase (AR) was determined in streptozotocin-induced diabetic rats, which were divied into normal control group (N group). diabetes control group (DM group) and TMP-treated group (T group). The positive expression of VEGF (vascular endithelial growth factor) in retina of each group was observed by immunohistochemical staining. Result: The positive expression of VEGF in retina and the activities of NOS and AR in retina of the T group rats was weaken significantly compared with the DM group, but still above normal level. Conclusion: TMP may prevent the development of diabetic retinopathy, and the effect may be partly achieved by repression the VEGF and restrained the activities of retinal NOS and AR.
出处
《中药药理与临床》
CAS
CSCD
2002年第5期18-20,共3页
Pharmacology and Clinics of Chinese Materia Medica
基金
福建省自然科学基金资助课题
编号 :c9810034